SEC Form 4 · accession 0001209191-15-071510
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Brett Primiano
Officer — SVP,CORP DEV,GEN COUNSEL&SEC.
Period of report
Sep 18, 2015
Accepted (ET)
Sep 21, 2015 · 8:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.94 | Sep 18, 2015 | A | 75,000 | A | — | Sep 17, 2025 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This option was granted on September 18, 2015. The shares underlying this option vest as to 25% of the shares on September 18, 2016, with the remaining 75% vesting in 36 equal monthly installments thereafter.